Asabys Partners

Asabys Partners is a venture capital manager specialized in the healthcare sector, founded by Josep Ll. Sanfeliu and Clara Campàs and participated by Alantra. Its first investment vehicle, Sabadell Asabys Health Innovation Investments SCR, SA, was launched in 2019 and is backed by the Banc Sabadell as reference investor. The fund has a target size of more than €80M and invests in healthcare companies across three verticals: medtech, digital therapeutics and biotech, that have highly innovative and disruptive technologies.

XesGalicia

XesGalicia is a management company of venture capital firms that focuses on promoting the economic and industrial development and consolidation of businesses in Galicia, from four different investment vehicles. XesGalicia offers financing to different types of projects, from new enterprise initiatives to established industrial projects with a long history.

Ministry of Science, Innovation and Universities  

The Ministry of Science, Innovation and Universities, within the call for R+D+i Projects «Challenges-Collaboration» of the State Program for Research, Development and Innovation Oriented towards the Challenges of Society, within the framework of the State Plan for Scientific and Technological Research and Innovation 2017-2020, has awarded grant funding to the project “Discovery and development of novel immuno-oncological and anti-fibrotic treatments with local effect” led by ORIGO BIOPHARMA S.L. with file number RTC2019-007449-1.

This project has been funded by the Ministry of Science, Innovation and Universities within the CHALLENGES-COLLABORATION Subprogram, Call 2019. The project is co-financed by the European Union with the aim of promoting technological development, innovation and quality research.

Center for Industrial Technological Development (CDTI)

The Center for Industrial Technological Development (CDTI) has granted financing for the Project Origo GI “discovery and development of new immunotherapies for organ restricted treatment of colorectal cancer and Crohn’s disease”, within its 2019 NEOTEC program.

(File number EXP-00122753/SNEO-20191050)

This project has been funded by the CDTI within the State Subprogram for Corporate R&D and Innovation within the State Plan Framework for Scientific and Technology Research and Innovation 2017-2020 and supported by the Spanish Ministry of Economy, Industry and Competitiveness.